Danaher, FDA autorizza test Beckman Coulter per distinguere infezioni batteriche e virali
- Beckman Coulter Diagnostics, controllata di Danaher, ottiene il via libera FDA al test Access MeMed BV per distinguere infezioni batteriche e virali.
- Destinato ad adulti e bambini dai 90 giorni, fornisce risultati in appena 15 minuti sull’analizzatore DxI 9000, senza richiedere nuovi strumenti.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire on November 03, 2026, and is solely responsible for the information contained therein.